scholarly journals Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome

2016 ◽  
pp. 7 ◽  
Author(s):  
Brian Lacy
Keyword(s):  
Irritable Bowel Syndrome ◽  
Diagnosis And Treatment ◽  
Irritable Bowel

Current Developments for the Diagnosis and Treatment of Irritable Bowel Syndrome

2010 ◽  
Vol 16 (33) ◽  
pp. 3638-3645 ◽  
Author(s):  
Oliver Grundmann ◽  
Saunjoo L. Yoon ◽  
Baharak Moshiree
Keyword(s):  
Irritable Bowel Syndrome ◽  
Diagnosis And Treatment ◽  
Irritable Bowel

scholarly journals “Gastrointestinal” comorbidity in irritable bowel syndrome

2021 ◽  
Vol 1 (6) ◽  
pp. 104-111
Author(s):  
O. V. Gaus ◽  
M. A. Livzan
Keyword(s):  
Irritable Bowel Syndrome ◽  
Clinical Practice ◽  
Characteristic Feature ◽  
Overlap Syndrome ◽  
Diagnosis And Treatment ◽  
Urgent Problem ◽  
Functional Disorders ◽  
Modern Information ◽  
Irritable Bowel ◽  
Real Clinical Practice

Among the large and heterogeneous group of patients with irritable bowel syndrome (IBS) comorbidity is characteristic feature. Comorbidity is an urgent problem in real clinical practice. Gastrointestinal comorbidity of a patient with IBS is associated with the presence of common pathogenetic links and is represented by combined pathology with functional disorders and the formation of “overlap syndrome” with organic diseases. Often, with a comorbid course, the phenomenon of “mutual burdening” is observed, when the severity of the course of each of them increases. All this requires optimization of approaches to the diagnosis and treatment of this cohort of patients. Obviously, with a comorbid course of IBS, it is advisable to prescribe drugs that affect the general links of pathogenesis, rather than focusing on individual symptoms. This article presents modern information on the gastrointestinal comorbidity of a patient with IBS.

scholarly journals Actual issues of diagnosis and treatment of irritable bowel syndrome

2019 ◽  
pp. 110-116
Author(s):  
D. I. Trukhan ◽  
V. V. Goloshubina ◽  
D. S. Ivanova
Keyword(s):  
Irritable Bowel Syndrome ◽  
Diagnostic Criteria ◽  
Clinical Manifestations ◽  
Diagnosis And Treatment ◽  
Bifidobacterium Infantis ◽  
Rome Criteria ◽  
International Consensus ◽  
Incorrect Diagnosis ◽  
Irritable Bowel ◽  
Number Of Publications

The problem of irritable bowel syndrome (IBS) remains relevant for practice internist and gastroenterologist, as evidenced by the large number of publications in recent years on this issue, affecting various aspects of the pathogenesis, clinical manifestations, diagnosis and treatment of IBS. The article describes the evolution of diagnostic criteria for IBS as part of an international consensus «Rome criteria». Lack of effect of the treatment of IBS ex juvantibus often not a consequence of an incorrect diagnosis, and due to the presence in the patient’s intestinal disorders microbiocenosis. In this situation, it is expedient to correct the microbial landscape of the intestine with the use of probiotic agents. Efficacy in reducing the symptoms of irritable bowel syndrome has reliably demonstrated specific strains of probiotics, such as Bifidobacterium infantis 35624.

Sign in / Sign up

Export Citation Format

Share Document